Literature DB >> 32437728

Immune mechanisms involved in sickle cell disease pathogenesis: current knowledge and perspectives.

Júlia Teixeira Cottas de Azevedo1, Kelen Cristina Ribeiro Malmegrim2.   

Abstract

Sickle cell disease (SCD) is caused by a single point mutation in the β-chain of the hemoglobin gene that results in the replacement of glutamic acid with valine in the hemoglobin protein. However, recent studies have demonstrated that alterations in several other genes, especially immune related genes, may be associated with complications of SCD. In fact, higher chronic inflammatory status is related to more severe clinical symptoms in SCD patients, suggesting crucial roles of the immune system in SCD physiopathology. Nevertheless, although participation of innate immune cells in SCD pathogenesis has been broadly and extensively described, little is known about the roles of the adaptive immune system in this disease. In addition, the influence of treatments on the immune system of SCD patients and their complications (such as alloimmunization) are not yet completely understood. Thus, we reviewed the current knowledge about the immune mechanisms involved in SCD pathogenesis. We suggest recommendations for future studies to allow for a broader understanding of SCD pathogenesis, helping in the development of new therapies and improvement in the life quality and expectancy of patients.
Copyright © 2020 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  adaptive immune system; immune biomarkers; immunity; immunoregulation; innate immune system; sickle cell disease

Mesh:

Substances:

Year:  2020        PMID: 32437728     DOI: 10.1016/j.imlet.2020.04.012

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  4 in total

1.  Allogeneic haematopoietic stem cell transplantation resets T- and B-cell compartments in sickle cell disease patients.

Authors:  Luciana Ribeiro Jarduli-Maciel; Júlia Teixeira Cottas de Azevedo; Emmanuel Clave; Thalita Cristina de Mello Costa; Lucas Coelho Marlière Arruda; Isabelle Fournier; Patrícia Vianna Bonini Palma; Keli Cristina Lima; Juliana Bernardes Elias; Ana Beatriz Pl Stracieri; Fabiano Pieroni; Renato Cunha; Luiz Guilherme Darrigo-Júnior; Carlos Eduardo Settani Grecco; Dimas Tadeu Covas; Ana Cristina Silva-Pinto; Gil Cunha De Santis; Belinda Pinto Simões; Maria Carolina Oliveira; Antoine Toubert; Kelen Cristina Ribeiro Malmegrim
Journal:  Clin Transl Immunology       Date:  2022-04-23

Review 2.  Acupuncture for Pain Management in Pediatric Patients with Sickle Cell Disease.

Authors:  Krystal S Plonski
Journal:  Children (Basel)       Date:  2022-07-19

Review 3.  Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing.

Authors:  Dito Anurogo; Nova Yuli Prasetyo Budi; Mai-Huong Thi Ngo; Yen-Hua Huang; Jeanne Adiwinata Pawitan
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

Review 4.  Challenges in the Management of Sickle Cell Disease During SARS-CoV-2 Pandemic.

Authors:  Faisal Alsayegh; Shaker A Mousa
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.